Clinical Trials Sponsored by Amager Hospital
Total 102809 results
-
AmgenCompletedLeukemia, Acute LymphoblasticItaly, United Kingdom, Belgium, Mexico, Germany, Russian Federation, Turkey, Spain, Australia, Poland, Austria, Czechia, France, Portugal, Israel, Denmark, Brazil, Romania, Sweden, Switzerland, Norway, Netherlands, Argentina, Greece
-
AmgenCompletedRelapsed/Refractory Philadelphia Positive B-precursor ALLFrance, United States, Germany, Italy, United Kingdom
-
AmgenCompletedPostmenopausal OsteoporosisUnited States, Canada, Denmark, Germany, Belgium, Colombia, Czechia, Japan, Mexico, Poland, Switzerland, Hungary, Spain, Australia, Romania, United Kingdom, India, Argentina, Brazil, Dominican Republic, Estonia, Latvia, Lithuania, New...
-
AmgenActive, not recruitingAtopic DermatitisUnited States, United Kingdom
-
AmgenCompletedRheumatoid ArthritisUnited States, Germany
-
AmgenCompletedPalmoplantaris PustulosisJapan
-
AmgenCompletedMelanomaUnited States, France, Germany
-
AmgenCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaCanada, Belgium, Spain, United States, Korea, Republic of, Australia, Czechia, Taiwan, Hungary, Austria, Romania, Japan, United Kingdom, Greece, Turkey, Bulgaria, France, Russian Federation, Poland
-
AmgenActive, not recruitingColorectal Cancer (CRC)France, Spain, Korea, Republic of, United States, United Kingdom, Taiwan, Italy, Greece, Australia, Japan, Germany, Mexico
-
AmgenCompletedUncontrolled Gout | Chronic GoutUnited States
-
AmgenActive, not recruitingIgG4 Related DiseasePoland, Spain, United States, Argentina, Australia, Canada, China, France, Germany, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Mexico, Netherlands, Sweden, Turkey, United Kingdom
-
AmgenCompletedSjögren's SyndromeUnited States, France, Italy, Hungary, Poland, Argentina, India, Korea, Republic of, Mexico, Peru, Taiwan, United Kingdom
-
AmgenActive, not recruitingThyroid Eye DiseaseUnited States, Spain, Germany, Italy, France, United Kingdom
-
AmgenCompletedChronic Spontaneous UrticariaUnited States, Korea, Republic of, Spain, Italy, Canada, Poland, Japan, France, Greece, Germany
-
AmgenActive, not recruitingAtopic DermatitisBelgium, Spain, China, Germany, United States, Austria, France, Hungary, Switzerland, Canada, United Kingdom, Bulgaria, Australia, Netherlands, Malaysia, Singapore, Slovenia, Italy, Japan, Argentina, Greece, Turkey, Poland, Puerto Rico, Romani... and more
-
AmgenCompletedHepatic ImpairmentUnited States
-
AmgenCompletedAcute Lymphoblastic LeukemiaGermany, United States, France, Australia, Spain, Italy, Netherlands, Austria, United Kingdom
-
AmgenCompletedBlincyto Use in Routine Clinical PracticeNetherlands, France, Czechia, Sweden, Austria, Italy, Switzerland, Germany, Finland, United Kingdom, Portugal, Greece, Poland
-
AmgenActive, not recruitingKRAS p, G12c Mutated /Advanced Metastatic NSCLCFinland, United States, Canada, Belgium, Spain, Korea, Republic of, Netherlands, United Kingdom, Australia, Denmark, Hungary, Sweden, Taiwan, Greece, Russian Federation, Switzerland, France, Italy, Japan, Poland, Brazil, Germany, Po...
-
AmgenActive, not recruitingNeuroendocrine Prostate CancerBelgium, United States, Austria, Spain, Australia, Netherlands, France, United Kingdom, Japan
-
AmgenActive, not recruitingAdvanced/Metastatic Solid Tumors With KRAS p.G12C MutationTaiwan, Hong Kong
-
AmgenTerminatedRelapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaUnited States, France, Italy, Belgium, Canada, Mexico, Germany, Korea, Republic of, United Kingdom, Taiwan, Australia, Spain, Austria, Israel, Czechia, Greece, Russian Federation, Poland, Turkey, Bulgaria, Ireland
-
AmgenCompletedPsoriasisAustria, Germany, Switzerland, United Kingdom, Ireland, Spain, Croatia, Czechia, Slovenia, Sweden
-
AmgenCompletedAtherosclerotic Cardiovascular DiseaseCanada, United States, Belgium, Spain, China, Korea, Republic of, Australia, Netherlands, Austria, Czechia, Taiwan, Hungary, Italy, Portugal, United Kingdom, Greece, Hong Kong, Turkey, France, Bulgaria, Germany, Finland, Japan, Sweden, ... and more
-
AmgenCompletedArthritis, PsoriaticUnited States, Spain, Netherlands, Canada, France, Russian Federation, Belgium, Austria, Germany, Italy, United Kingdom
-
AmgenActive, not recruitingRelapsed Refractory Multiple MyelomaIndia
-
AmgenTerminatedNSCLC | Non-small Cell Lung CancerUnited States, Austria, Australia
-
AmgenCompletedPlaque PsoriasisUnited States, Canada, Poland, Estonia, Germany, Hungary, Latvia, Lithuania
-
AmgenCompletedChorioretinal Vascular DiseaseUnited States
-
AmgenCompletedMigraineUnited States, Spain, Czechia, Hungary, Italy, Portugal, Poland, Bulgaria, Romania
-
AmgenTerminatedMetastatic Castration-resistant Prostate CancerUnited States, Sweden, Spain, United Kingdom, Australia, Denmark
-
AmgenTerminatedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Japan, Germany, Netherlands, Canada
-
AmgenNo longer availableNon Small-cell Lung Cancer | Locally Advanced Unresectable NSCLC | Locally Advanced Metastatic NSCLCUnited States, Taiwan, Israel, Saudi Arabia, Brazil, Argentina
-
AmgenCompletedElevated Serum Lipoprotein(a)Hong Kong
-
AmgenCompleted
-
AmgenSuspendedA Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLCSmall Cell Lung CancerUnited States
-
AmgenCompletedCardiovascular DiseaseUnited States, Australia, Netherlands, Canada, Denmark, Iceland, Japan
-
AmgenTerminatedAcute Myeloid LeukemiaUnited States, Australia, Germany
-
AmgenCompletedAnti-neutrophil Cytoplasmic Antibody-associated VasculitisUnited States
-
AmgenCompletedAnti-neutrophil Cytoplasmic Antibody-associated VasculitisJapan
-
AmgenCompletedUnresectable Stage IIIB-IV Malignant MelanomaJapan
-
AmgenTerminatedMUC17-positive Solid TumorsUnited States, Korea, Republic of, Taiwan, Spain, Austria, France, Japan, Germany, Netherlands
-
AmgenCompleted
-
AmgenWithdrawnRelapsed/Refractory Acute Myeloid LeukemiaUnited States
-
AmgenCompletedParapsoriasisUnited States
-
AmgenCompletedCompletely Resectable Stage IIIB, IIIC, or IVM1a MelanomaUnited States, Poland, France, Russian Federation, Spain, Australia, Greece, Switzerland, Brazil
-
AmgenCompletedChronic Graft-versus-Host Disease (cGVHD)Australia
-
AmgenCompletedA Study to Assess the Effect of Food on the Pharmacokinetics (PK) of AMG 510 in Healthy ParticipantsHealthy ParticipantsUnited States
-
AmgenTerminatedAcute Myeloid Leukemia | Multiple Myeloma | AML | Myelodysplastic Syndrome | MDS | Non-Hodgkins Lymphoma | NHLUnited States, Australia, Italy, France, Greece, Japan
-
AmgenCompletedDyslipidemiaUnited States, Poland, Czechia, Hungary, Russian Federation, Ukraine, Slovakia